Senior Consultant (Medical Oncologist)
Department of Haematology-Oncology
National University Cancer Institute
Dr Tan is a consultant medical oncologist at the National University Cancer Institute, Singapore and an Associate Professor in the Department of Medicine at the Yong Loo Lin School of Medicine, National University of Singapore. He graduated from Guy’s, King’s and St Thomas’ School of Medicine in London, UK and trained in internal medicine at Hammersmith and Guy’s and St Thomas’ Hospitals. He obtained his PhD in Oncology at the Institute of Cancer research in London and trained in Medical Oncology at the Royal Marsden Hospital in London and Princess Margaret Cancer Centre in Toronto, Canada. His primary clinical and research interests are in gynaecological cancers, precision oncology, and early phase trials. He is the founding President of the Gynecologic Cancer Group Singapore (GCGS), and chairman of the Asia-Pacific Gynaecologic Oncology Trials (APGOT) Group. He currently also co-chairs the Cervical Cancer Research Network (CCRN) of the Gynecologic Cancer InterGroup (GCIG).
Moderator for Ethical Challenges of IRBs in Singapore
Singapore has long been a leader in clinical research from the early days of the 20th century. The landscape however has changed dramatically in the last few decades with the advent of strong commercial pressures as well as increasing regulatory oversight. While researchers often complain about the slow pace of IRB handling of research protocols, given tight deadlines from funding agencies, the IRB perspective is often neglected. There are numerous examples of issues which have arisen in IRB approved studies in Singapore. The challenge is to have a workable approach which protects human subjects while facilitating cutting edge research to deal with the challenges of human health in Singapore and beyond.
< Back to Speakers' Information
Subcribe to our mailing list to get the latest education updates.